. . . . . . . "[These findings identify NF-?B and interferon signatures as clinical features of ccRCC, provide strong rationale for the incorporation of NF-?B inhibitors and/or and the exploitation of interferon signaling in the treatment of ccRCC, and supply new NF-?B targets for potential therapeutic intervention in this currently-incurable malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:59+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .